Could this drug couponing start-up be headed for IPO or is it a takeover target? Either way, it's helping consumers save billions at the pharmacy.
News & Analysis: McKesson
These three companies dominate the industry, and all provide growth with a nice dividend.
MCK earnings call for the period ending March 31, 2020.
The healthcare giant delivered across-the-board sales growth despite COVID-19 headwinds.
Bristol Myers Squibb, Cardinal Health, and McKesson are all underpriced.
The consumer foods giant pulled its 2020 outlook but expects to resume its short-term forecasting in June.
Shares fell by as much as 45% in light of the news.
The three big drug distributors have been in talks for months in the hopes of finding a global settlement.
MCK earnings call for the period ending December 31, 2019.
Bankruptcies reached a high not seen since 2011, with opioid lawsuits playing a big role.